JP2002539156A5 - - Google Patents

Download PDF

Info

Publication number
JP2002539156A5
JP2002539156A5 JP2000604837A JP2000604837A JP2002539156A5 JP 2002539156 A5 JP2002539156 A5 JP 2002539156A5 JP 2000604837 A JP2000604837 A JP 2000604837A JP 2000604837 A JP2000604837 A JP 2000604837A JP 2002539156 A5 JP2002539156 A5 JP 2002539156A5
Authority
JP
Japan
Prior art keywords
carbon atoms
branched
linear
alkyl
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000604837A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002539156A (ja
JP4392473B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/006669 external-priority patent/WO2000054761A2/en
Publication of JP2002539156A publication Critical patent/JP2002539156A/ja
Publication of JP2002539156A5 publication Critical patent/JP2002539156A5/ja
Application granted granted Critical
Publication of JP4392473B2 publication Critical patent/JP4392473B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000604837A 1999-03-18 2000-03-14 ホスホリパーゼdの活性の調節 Expired - Fee Related JP4392473B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12519499P 1999-03-18 1999-03-18
US60/125,194 1999-03-18
PCT/US2000/006669 WO2000054761A2 (en) 1999-03-18 2000-03-14 Regulation of phospholipase d activity

Publications (3)

Publication Number Publication Date
JP2002539156A JP2002539156A (ja) 2002-11-19
JP2002539156A5 true JP2002539156A5 (US20080131398A1-20080605-C00009.png) 2005-05-19
JP4392473B2 JP4392473B2 (ja) 2010-01-06

Family

ID=22418604

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000604837A Expired - Fee Related JP4392473B2 (ja) 1999-03-18 2000-03-14 ホスホリパーゼdの活性の調節

Country Status (10)

Country Link
US (5) US6353026B1 (US20080131398A1-20080605-C00009.png)
EP (2) EP1162976B1 (US20080131398A1-20080605-C00009.png)
JP (1) JP4392473B2 (US20080131398A1-20080605-C00009.png)
AT (1) ATE466582T1 (US20080131398A1-20080605-C00009.png)
AU (1) AU780114B2 (US20080131398A1-20080605-C00009.png)
CA (2) CA2645558C (US20080131398A1-20080605-C00009.png)
DE (1) DE60044335D1 (US20080131398A1-20080605-C00009.png)
ES (1) ES2344138T3 (US20080131398A1-20080605-C00009.png)
HK (1) HK1043306B (US20080131398A1-20080605-C00009.png)
WO (1) WO2000054761A2 (US20080131398A1-20080605-C00009.png)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650435A (en) * 1991-04-01 1997-07-22 Madara; James L. Modulation of inflammation related to columnar epithelia
US6745204B1 (en) * 1999-02-12 2004-06-01 Mount Sinai Hospital System for electronically managing, finding, and/or displaying biomolecular interactions
AU2529500A (en) * 1999-02-12 2000-08-29 Mount Sinai Hospital Corporation System for electronically managing, finding, and/or displaying biomolecular interactions
US6387953B1 (en) * 1999-03-18 2002-05-14 Brigham And Women's Hopsital Inhibition of TNF-(α)-initiated neutrophil response
DK1163204T3 (da) * 1999-03-18 2005-12-19 Brigham & Womens Hospital Lipoxinforbindelser og deres anvendelse
ATE466582T1 (de) * 1999-03-18 2010-05-15 Brigham & Womens Hospital 16-phenoxy-lipoxin analoge zur medizinischen verwendung
EP1586550A1 (en) * 1999-03-18 2005-10-19 The Brigham And Women's Hospital, Inc. Lipoxin compounds and their use
CN1951899B (zh) 2000-02-16 2012-02-01 布里格姆及妇女医院股份有限公司 阿司匹林触发的脂质介体
WO2001070664A2 (en) * 2000-03-20 2001-09-27 Trustees Of Boston University Lipoxin analogs and methods for the treatment of periodontal disease
GB0119583D0 (en) * 2001-08-10 2001-10-03 Unilever Plc Cosmetic composition and method of treating skin
WO2003039533A1 (en) * 2001-11-06 2003-05-15 The Brigham And Women's Hospital, Inc. Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases
US6831186B2 (en) 2001-11-06 2004-12-14 Schering Aktiengesellschft Lipoxin A4 analogs
EP2361622A1 (en) * 2001-12-18 2011-08-31 The Brigham and Women's Hospital Use of lipoxin analogs to promote cell defense against gram-negative infections
US8481772B2 (en) 2002-04-01 2013-07-09 University Of Southern California Trihydroxy polyunsaturated eicosanoid derivatives
US7902257B2 (en) * 2002-04-01 2011-03-08 University Of Southern California Trihydroxy polyunsaturated eicosanoid
US7759395B2 (en) 2002-08-12 2010-07-20 The Brigham And Women's Hospital, Inc. Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
EP1537067B1 (en) * 2002-08-12 2009-11-18 Brigham And Women's Hospital Resolvins: biotemplates for therapeutic interventions
WO2004078143A2 (en) * 2003-03-05 2004-09-16 The Brigham And Women's Hospital Inc. Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogs
WO2005105025A1 (en) * 2004-04-14 2005-11-10 Boston University Methods and compositions for preventing or treating periodontal diseases
EP1910547A2 (en) 2005-07-29 2008-04-16 Monsanto Technology, LLC Development of novel germplasm using segregates from transgenic crosses
US8273792B2 (en) * 2005-10-03 2012-09-25 The Brigham And Women's Hospital, Inc. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and it's natural stereoisomers
EP1954291A1 (en) * 2005-11-18 2008-08-13 Trustees Of Boston University Treatment and prevention of bone loss using resolvins
WO2007127377A2 (en) * 2006-04-28 2007-11-08 Resolvyx Pharmaceuticals, Inc. Combinations comprising omega-3 fatty acid compounds for the treatment of cardiovascular disease
CN101528218A (zh) * 2006-07-19 2009-09-09 雷索维克斯药品公司 治疗粘膜炎的组合物和方法
EP2131833A2 (en) * 2006-10-26 2009-12-16 Resolvyx Pharmaceuticals, Inc. Use of resolvins for inhibition of bone loss
UY30755A1 (es) 2006-12-04 2008-07-31 Bayer Schering Pharma Ag Sal de potasio cristalina de analogos de lipoxina a4
WO2008070129A2 (en) * 2006-12-05 2008-06-12 Resolvyx Pharmaceuticals, Inc. Compositions and methods for the treatment of inflammatory disease
EP2207543A2 (en) * 2007-09-14 2010-07-21 Resolvyx Pharmaceuticals, Inc. Omega-3 fatty acids, hydroxy polyunsaturated fatty acids, lipoxin compounds, or oxylipin compounds for treating autoimmune diseases or inhibiting immune function
WO2009051670A2 (en) * 2007-10-12 2009-04-23 Resolvyx Pharmaceuticals, Inc. Oxylipin compounds for the treatment of ophthalmic conditions
KR101306199B1 (ko) 2012-01-31 2013-09-09 부산대학교 산학협력단 포스포리파아제 d 억제제를 유효성분으로 포함하는 골다공증 예방 및 치료용 약학적 조성물
US9447678B2 (en) 2012-12-01 2016-09-20 Halliburton Energy Services, Inc. Protection of electronic devices used with perforating guns

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411951A (en) 1984-10-04 1995-05-02 Monsanto Company Prolonged release of biologically active somatotropin
US5650435A (en) 1991-04-01 1997-07-22 Madara; James L. Modulation of inflammation related to columnar epithelia
ES2313715T3 (es) * 1993-06-15 2009-03-01 The Brigham And Women's Hospital, Inc. Compuestos de lipoxina con semivida prolongada.
US5441951A (en) * 1994-06-15 1995-08-15 Brigham & Women's Hospital Lipoxin compounds
WO1995001179A1 (en) * 1993-06-29 1995-01-12 Brigham & Women's Hospital Modulation of inflammation related to columnar epithelia
US5750354A (en) 1994-03-11 1998-05-12 Brigham And Women's Hospital Lipoxin transport system and uses therefor
US6387953B1 (en) * 1999-03-18 2002-05-14 Brigham And Women's Hopsital Inhibition of TNF-(α)-initiated neutrophil response
ATE466582T1 (de) * 1999-03-18 2010-05-15 Brigham & Womens Hospital 16-phenoxy-lipoxin analoge zur medizinischen verwendung
DK1163204T3 (da) * 1999-03-18 2005-12-19 Brigham & Womens Hospital Lipoxinforbindelser og deres anvendelse

Similar Documents

Publication Publication Date Title
JP2002539156A5 (US20080131398A1-20080605-C00009.png)
JP2002539181A5 (US20080131398A1-20080605-C00009.png)
JP2005511592A5 (US20080131398A1-20080605-C00009.png)
JP2002539159A5 (US20080131398A1-20080605-C00009.png)
JP2005533835A5 (US20080131398A1-20080605-C00009.png)
JP2002502874A5 (US20080131398A1-20080605-C00009.png)
CA2645558A1 (en) Regulation of phospholipase d activity
JP2002508352A5 (ja) 4(3)置換−4(3)−アミノメチル−(チオ)ピラン又はピペリジン誘導体(=ガバペンチン類似体)
JP2001526218A5 (US20080131398A1-20080605-C00009.png)
RU2000124100A (ru) Лиганды рецептора h3 гистамина
JP2002533472A5 (US20080131398A1-20080605-C00009.png)
JP2001512743A5 (US20080131398A1-20080605-C00009.png)
JP2004531544A5 (US20080131398A1-20080605-C00009.png)
RU99128073A (ru) Замещенные 2-(2,6-диоксопиперидин-3-ил)-фталимиды и -1-оксоизоиндолины и способ снижения уровней фноа
RU2000132188A (ru) Производные эпотилонов, их синтез и применение
CA2615917A1 (en) Use of lipoxin compounds for inhibiting of tnf-(alpha)initiated neutrophil response
JP2002527474A5 (ja) 躁病および双極性障害の治療のための医薬
RU97110664A (ru) Производное индола
JP2004517813A5 (US20080131398A1-20080605-C00009.png)
JP2002539298A5 (US20080131398A1-20080605-C00009.png)
JP2002505323A5 (US20080131398A1-20080605-C00009.png)
JP2002527414A5 (US20080131398A1-20080605-C00009.png)
KR960037675A (ko) 벤조니트릴 및 벤조플루오라이드
RU95117068A (ru) Антигипертриглицеридемическая композиция, способ ее получения, способ лечения или профилактики гипертриглицеридемии, применение соединений
KR840007596A (ko) 유기인 유도체의염의 제조방법